ProShares MSCI Transformational Changes ETF ANEW
Set alert
As of Oct 12, 9:46 AM ET
- YTD
- -0.05%
- 1 year
- -0.05%
- Open
- 54.66
- Prev close
- 54.68
- Mkt cap
- 8.16M
- Vol
- 7
- Avg vol
- 7
- EPS
- 2.20
- P/E
- 24.82
- Div yield
- 0.00%
More statistics
- Low
- 54.66
- High
- 54.66
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 46.04
- 200-d avg
- 43.09
News
1 month ago seekingalpha.com
How Policy, Geopolitics And AI Are Reshaping Markets
Markets are broader than headlines suggest. AI is driving wider economic growth in Canada. Why Canada is positioned to benefit from the AI buildout.
3 months ago seekingalpha.com
AI's Biggest Gainers
AI is everywhere in the product. But revenue growth is decelerating, from 16% to 13% to 12% guided. The productivity benefits are arriving for users and end-consumers of AI, though it's not hitting…
1 year ago benzinga.com
Davos 2025: ETFs To Tackle Geopolitical, Climate, Cyber Risks
WEF's 2025 Global Risks Report highlights geopolitical tensions, climate change, and disinformation as major challenges. ETFs can help investors navigate these risks with defense, clean energy, and…
2 years ago prismmediawire.com
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
Strategic Rebranding Reflects Focus on Neurodegenerative Therapies and Healthy Longevity New York, NY, September 17, 2024 – PRISM MediaWire – The Board of ANEW MEDICAL, INC. (NASDAQ: WENA), today…
2 years ago globenewswire.com
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The Board of ANEW MEDICAL, INC.
2 years ago prismmediawire.com
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy
Company will use novel, patented Klotho Gene (s-KL) in studies New York, NY, September 4, 2024 – PRISM MediaWire – ANEW MEDICAL, INC. (NASDAQ: WENA), a U.S. biotechnology company, announced that it…
2 years ago globenewswire.com
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC.
2 years ago prismmediawire.com
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
Successful Conversion Eliminates Over $4 Million in Long-Term Debt New York, NY, August 26, 2024 – ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and…
-
2 years ago globenewswire.com
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases,…
2 years ago prismmediawire.com
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
New York, NY. August 21, 2024 – ANEW MEDICAL, INC.
2 years ago globenewswire.com
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or the “Company”) (Nasdaq: WENA) announced the signing of an exclusive worldwide license agreement with Transfertech Sherbrooke…
2 years ago prismmediawire.com
ANEW MEDICAL, INC. Appoints New CFO
New York, NY, August 19, 2024 – ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S.
-
2 years ago globenewswire.com
ANEW MEDICAL, INC. Appoints New CFO
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S.-based biotechnology company focused on developing cell and gene-based treatments for…
2 years ago prismmediawire.com
ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases
Issuance of the Klotho gene-therapy patent will be instrumental in protecting ANEW's IP for development and commercialization in the U.S. New York, NY, August 15, 2024 – ANEW MEDICAL, INC. (“ANEW” or…
2 years ago globenewswire.com
ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases
Issuance of the Klotho gene-therapy patent will be instrumental in protecting ANEW's IP for development and commercialization in the U.S. Issuance of the Klotho gene-therapy patent will be…
2 years ago prismmediawire.com
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
NEW YORK, NY, August 09, 2024 – ANEW MEDICAL, INC.
2 years ago globenewswire.com
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
Melanocortin receptors on neurons in the brain control feeding and weight loss Patented peptide molecules delivered orally as a pill can control feeding disorders and weight loss NEW YORK, Aug. 09,…
2 years ago prismmediawire.com
ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments
Genomics data suggests having an active Klotho gene sequence may help people live longer, healthier lives The Company was granted patents in Europe, China, and Hong Kong and awaits issuance of…
2 years ago globenewswire.com
ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments
Genomics data suggests having an active Klotho gene sequence may help people live longer, healthier lives The Company was granted patents in Europe, China, and Hong Kong and awaits issuance of…
2 years ago prismmediawire.com
ANEW MEDICAL Forms Strategic Partnership with Japan's Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene
Collaboration focuses on research and development of ANEW's patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW's mission is to deliver transformative protein,…
2 years ago globenewswire.com
ANEW MEDICAL Forms Strategic Partnership with Japan's Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene
Collaboration focuses on research and development of ANEW's patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW's mission is to deliver transformative protein,…